Named after KU’s former technology transfer director, the Baxendale Commercialization award recognizes a KU faculty member who excels in translational research and research commercialization, i.e., translating academic discoveries into commercially viable products that benefit society. The award was first presented in 2005 to Val Stella, University Distinguished Professor of Pharmaceutical Chemistry, as the KU Technology Transfer Leadership Award. It was renamed in 2012 and will now be given annually.
Building on her more than 15 years of experience in the area of diabetes research, Stehno-Bittel co-founded Likarda LLC in 2012. The startup company, located at the Bioscience & Technology Business Center at KU Medical Center, has successfully cured diabetes in laboratory rats by transplanting its engineered cell clusters, known as Kanslets. Eventually, with further testing and development, the clusters could be transplanted in companion animals using a minimally invasive surgical procedure.
To read the full, original article click on this link: KUMC Researcher Receives Baxendale Commercialization Award - Watch List News
